Arcturus Therapeutics Holdings Inc. (ARCT)
USD 9.16
(-3.43%)
USD 9.16
(-3.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -316.78 Million USD | -5.24% |
| 2022 | -301.01 Million USD | 0.62% |
| 2021 | -302.88 Million USD | 31.94% |
| 2020 | -445.02 Million USD | -763.99% |
| 2019 | -51.5 Million USD | -92.21% |
| 2018 | -26.79 Million USD | -7.34% |
| 2017 | -24.96 Million USD | -1049.93% |
| 2016 | -2.17 Million USD | 86.97% |
| 2015 | -16.65 Million USD | -665.53% |
| 2014 | -2.17 Million USD | 90.15% |
| 2013 | -22.09 Million USD | -4010.62% |
| 2012 | 565 Thousand USD | 1127.27% |
| 2011 | -55 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -284.44 Million USD | -10.91% |
| 2024 Q1 | -256.47 Million USD | 19.04% |
| 2023 Q2 | -291.26 Million USD | 2.5% |
| 2023 Q4 | -316.78 Million USD | -19.59% |
| 2023 FY | -316.78 Million USD | -5.24% |
| 2023 Q1 | -298.74 Million USD | 0.75% |
| 2023 Q3 | -264.9 Million USD | 9.05% |
| 2022 Q2 | -185.09 Million USD | 26.1% |
| 2022 FY | -301.01 Million USD | 0.62% |
| 2022 Q4 | -301.01 Million USD | -110.59% |
| 2022 Q3 | -142.93 Million USD | 22.78% |
| 2022 Q1 | -250.47 Million USD | 17.3% |
| 2021 Q2 | -371.9 Million USD | 6.65% |
| 2021 Q4 | -302.88 Million USD | 17.38% |
| 2021 Q1 | -398.41 Million USD | 9.89% |
| 2021 FY | -302.88 Million USD | 31.94% |
| 2021 Q3 | -366.6 Million USD | 1.43% |
| 2020 Q3 | -287.79 Million USD | -149.56% |
| 2020 Q4 | -442.14 Million USD | -53.63% |
| 2020 FY | -445.02 Million USD | -763.99% |
| 2020 Q1 | -39.81 Million USD | 22.7% |
| 2020 Q2 | -115.32 Million USD | -189.65% |
| 2019 FY | -51.5 Million USD | -92.21% |
| 2019 Q3 | -59.09 Million USD | -48.44% |
| 2019 Q1 | -15.04 Million USD | 43.87% |
| 2019 Q2 | -39.8 Million USD | -164.65% |
| 2019 Q4 | -51.5 Million USD | 12.83% |
| 2018 Q3 | -30.33 Million USD | 23.75% |
| 2018 FY | -26.79 Million USD | -7.34% |
| 2018 Q2 | -39.77 Million USD | -181.89% |
| 2018 Q1 | 48.57 Million USD | 294.56% |
| 2018 Q4 | -26.79 Million USD | 11.65% |
| 2017 Q1 | -4.67 Million USD | -115.0% |
| 2017 Q4 | -24.96 Million USD | -730.23% |
| 2017 FY | -24.96 Million USD | -1049.93% |
| 2017 Q3 | -3 Million USD | 15.72% |
| 2017 Q2 | -3.56 Million USD | 23.66% |
| 2016 FY | -2.17 Million USD | 86.97% |
| 2016 Q2 | -15.09 Million USD | -11.91% |
| 2016 Q4 | -2.17 Million USD | 50.31% |
| 2016 Q1 | -13.48 Million USD | 19.04% |
| 2016 Q3 | -4.37 Million USD | 71.01% |
| 2015 Q3 | -9.97 Million USD | -16.34% |
| 2015 FY | -16.65 Million USD | -665.53% |
| 2015 Q4 | -16.65 Million USD | -67.08% |
| 2015 Q2 | -8.57 Million USD | 0.0% |
| 2014 FY | -2.17 Million USD | 90.15% |
| 2014 Q2 | -6.91 Million USD | 33.49% |
| 2014 Q3 | -2.71 Million USD | 60.73% |
| 2014 Q1 | -10.39 Million USD | 52.97% |
| 2014 Q4 | -2.17 Million USD | 19.82% |
| 2013 FY | -22.09 Million USD | -4010.62% |
| 2013 Q3 | -4.54 Million USD | 74.19% |
| 2013 Q2 | -17.59 Million USD | 0.0% |
| 2013 Q4 | -22.09 Million USD | -386.67% |
| 2012 Q4 | 565 Thousand USD | 0.0% |
| 2012 FY | 565 Thousand USD | 1127.27% |
| 2011 FY | -55 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -466.301% |
| Alkermes plc | -166.73 Million USD | -89.991% |
| Agenus Inc. | 274.13 Million USD | 215.559% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 116.941% |
| Aptorum Group Limited | 1.35 Million USD | 23444.013% |
| Ardelyx, Inc. | 34.51 Million USD | 1017.91% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 7501.612% |
| Bicycle Therapeutics plc | -481.46 Million USD | 34.203% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 976.003% |
| ChromaDex Corporation | -24.04 Million USD | -1217.32% |
| Chimerix, Inc. | -25.51 Million USD | -1141.482% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 4646.291% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1237.961% |
| CRISPR Therapeutics AG | -150.84 Million USD | -110.01% |
| Precision BioSciences, Inc. | -85.41 Million USD | -270.904% |
| Dyadic International, Inc. | -6.37 Million USD | -4866.825% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1888.257% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4232.929% |
| Lantern Pharma Inc. | -21.7 Million USD | -1359.637% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -186.591% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3608.094% |
| Incyte Corporation | -3.17 Billion USD | 90.023% |
| IO Biotech, Inc. | -140.69 Million USD | -125.154% |
| Jaguar Health, Inc. | 29.39 Million USD | 1177.844% |
| Novavax, Inc. | -298.29 Million USD | -6.2% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 6035.713% |
| Opthea Limited | 28.15 Million USD | 1225.063% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1786.884% |
| ContextLogic Inc. | -232 Million USD | -36.547% |
| MiMedx Group, Inc. | -33.9 Million USD | -834.453% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3207.298% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -13572.219% |
| NextCure, Inc. | -6.47 Million USD | -4790.983% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -527.293% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4866.123% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2704.473% |
| Vaxcyte, Inc. | -368.22 Million USD | 13.969% |
| PDS Biotechnology Corporation | -32.7 Million USD | -868.51% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1933.482% |
| Pharming Group N.V. | 109.8 Million USD | 388.504% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1721.045% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -80.785% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1610.537% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1610.537% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4361.817% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -5305.956% |
| Acelyrin, Inc. | -216.9 Million USD | -46.051% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -5546.594% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -18275.232% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1013.621% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -4556.607% |
| Senti Biosciences, Inc. | 1.74 Million USD | 18306.264% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -71.602% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -309.019% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5125.817% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 317622.477% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 50544.108% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -170.653% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -88.304% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 385.73% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4070.471% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -145.356% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 4694.742% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -30.708% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1709.211% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -0.027% |
| MEI Pharma, Inc. | -3.7 Million USD | -8450.31% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2632.084% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 295.861% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1239.816% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4232.929% |
| Precigen, Inc. | -481 Thousand USD | -65760.499% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2349.762% |
| AlloVir, Inc. | -62.69 Million USD | -405.31% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -469.621% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 613.717% |
| ImmuCell Corporation | 10.99 Million USD | 2982.373% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -105.512% |
| Onconetix, Inc. | 5.33 Million USD | 6041.906% |
| PureTech Health plc | -167.19 Million USD | -89.471% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -940.016% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1557.02% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -6353.229% |
| Seer, Inc. | -4.24 Million USD | -7371.439% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1217.922% |
| Innoviva, Inc. | 255.56 Million USD | 223.957% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -467.072% |
| ESSA Pharma Inc. | -33.62 Million USD | -842.219% |
| GlycoMimetics, Inc. | -40.98 Million USD | -672.95% |
| GT Biopharma, Inc. | -1.02 Million USD | -30927.326% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -367.358% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 617.147% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -136.27% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2186.295% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -997.219% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -420412.65% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -926.469% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3765.705% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -10024.231% |
| Soligenix, Inc. | -4.95 Million USD | -6297.714% |
| Century Therapeutics, Inc. | 847 Thousand USD | 37501.299% |
| Kura Oncology, Inc. | -20.11 Million USD | -1474.655% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -674.053% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3672.196% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 17489.794% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -9808.946% |
| Autolus Therapeutics plc | -186.59 Million USD | -69.77% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -542.522% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -14.864% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1024.446% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 292.732% |
| GRI Bio, Inc. | -1.79 Million USD | -17558.25% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3426.521% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -852.548% |
| IGM Biosciences, Inc. | -72.6 Million USD | -336.312% |
| INmune Bio, Inc. | -25.41 Million USD | -1146.661% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 309.862% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -525.336% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1849.546% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -10880.836% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 933.326% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -669.185% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1093.536% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 183.817% |
| Verastem, Inc. | -37.27 Million USD | -749.801% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3391.557% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -510.831% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1993.089% |
| Histogen Inc. | -7.48 Million USD | -4131.187% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1366.153% |
| Surrozen, Inc. | -32.66 Million USD | -869.841% |
| Organovo Holdings, Inc. | -1.5 Million USD | -20921.168% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -7436.336% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1770.81% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 12209.671% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 7722.449% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3679.78% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -629.223% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2073.232% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -43772.947% |
| Apollomics, Inc. | -27.39 Million USD | -1056.375% |
| Amarin Corporation plc | -191.04 Million USD | -65.823% |
| Mesoblast Limited | 55.96 Million USD | 666.069% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2072.168% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1152.526% |
| Synaptogenix, Inc. | -28.66 Million USD | -1005.277% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -33744.979% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 750.064% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -36646.67% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4259.834% |
| Exelixis, Inc. | -73.05 Million USD | -333.661% |
| Better Therapeutics, Inc. | -860 Thousand USD | -36735.93% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1219.24% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -31.246% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 43138.124% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4158.984% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 25362.281% |
| Gritstone bio, Inc. | 39.49 Million USD | 902.201% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -276.677% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -11935.416% |
| Avid Bioservices, Inc. | 169.72 Million USD | 286.645% |
| Insmed Incorporated | 721.62 Million USD | 143.9% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3365.39% |
| MediWound Ltd. | -5.32 Million USD | -5852.443% |
| OmniAb, Inc. | 9.2 Million USD | 3542.236% |
| Alector, Inc. | -35.63 Million USD | -788.933% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 468.484% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -6328.348% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2492.847% |
| Zai Lab Limited | -775 Million USD | 59.124% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 193.021% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1371.726% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -284.08% |
| Immunic, Inc. | -45.34 Million USD | -598.697% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -63.957% |
| Veracyte, Inc. | -203.82 Million USD | -55.423% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 149.631% |
| FibroGen, Inc. | 56.76 Million USD | 658.051% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3657.428% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -11105.512% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -15201.244% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 106.901% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -9381.862% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -90.878% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1873.536% |
| Galecto, Inc. | -21.21 Million USD | -1393.161% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1231.886% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 120.185% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1194.496% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2653.011% |
| XBiotech Inc. | -200.02 Million USD | -58.376% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -276.677% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 7096.223% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -798.361% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -310.253% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 5666.491% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -85.893% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -242.942% |
| Vaxxinity, Inc. | 10.13 Million USD | 3226.619% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 143.026% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2842.071% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -380.304% |
| NexImmune, Inc. | -3.13 Million USD | -10009.288% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -9075.181% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1996.351% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1068.963% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3429.268% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -254195.806% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -680.807% |
| Ainos, Inc. | 4.07 Million USD | 7868.381% |
| Pluri Inc. | 22.82 Million USD | 1487.66% |
| Prothena Corporation plc | -608.34 Million USD | 47.926% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -166.756% |
| Celularity Inc. | 65.19 Million USD | 585.947% |
| Rallybio Corporation | -24.1 Million USD | -1214.368% |
| Cue Biopharma, Inc. | -33.81 Million USD | -836.719% |
| MeiraGTx Holdings plc | -40.3 Million USD | -686.038% |
| Omeros Corporation | 331.17 Million USD | 195.656% |
| Humacyte, Inc. | -22.48 Million USD | -1308.828% |
| Immunocore Holdings plc | -358.59 Million USD | 11.658% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1189.07% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -925.174% |
| Blueprint Medicines Corporation | 702.83 Million USD | 145.073% |
| CalciMedica, Inc. | -5.53 Million USD | -5628.553% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -68.308% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3001.518% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -691.241% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -852.663% |
| Pulmatrix, Inc. | -10.41 Million USD | -2941.077% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -5200.134% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -730.552% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -184.366% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -428.475% |
| Cytokinetics, Incorporated | 642.37 Million USD | 149.316% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -5340.306% |
| Nutriband Inc. | -251.65 Thousand USD | -125781.259% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -828.483% |
| Vor Biopharma Inc. | 4.3 Million USD | 7467.186% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 94.752% |
| Evogene Ltd. | -19.63 Million USD | -1513.472% |
| ProKidney Corp. | -56.23 Million USD | -463.321% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -550.865% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3329.496% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 123.227% |
| CorMedix Inc. | -43.05 Million USD | -635.82% |
| BioLineRx Ltd. | 7.33 Million USD | 4418.28% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1053.428% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 786.478% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1009.283% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 14302.416% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1288.451% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1886.236% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -321.969% |
| MediciNova, Inc. | -50.78 Million USD | -523.803% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -301.991% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1408164.059% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4809.487% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -58.536% |
| Biomea Fusion, Inc. | -166.57 Million USD | -90.184% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -77.002% |
| Mereo BioPharma Group plc | -51.46 Million USD | -515.495% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -234.011% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -7.84% |
| Absci Corporation | -72.59 Million USD | -336.361% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7037.998% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -35.128% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -236.255% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -231.037% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -710.762% |
| Allakos Inc. | -24.97 Million USD | -1168.424% |
| Imunon, Inc. | -4.21 Million USD | -7417.801% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2048.888% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -133.965% |
| BioAtla, Inc. | -109.01 Million USD | -190.603% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 43138.124% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -33636.848% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2747.409% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1394.076% |
| XOMA Corporation | -29 Million USD | -992.376% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1812.977% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3413.631% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4152.772% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -154.171% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -52.182% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -287.372% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -241.504% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -36770.915% |
| Akari Therapeutics, Plc | -3.84 Million USD | -8138.986% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 19620.054% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 122.941% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -26562.711% |
| UroGen Pharma Ltd. | 4.39 Million USD | 7314.507% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 379.156% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 440317.059% |
| Orgenesis Inc. | 21.78 Million USD | 1554.228% |
| Entera Bio Ltd. | -10.62 Million USD | -2880.421% |
| GH Research PLC | -78.07 Million USD | -305.739% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1321.343% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1088.3% |
| Xencor, Inc. | 29.64 Million USD | 1168.645% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -15982.195% |
| Replimune Group, Inc. | 1.41 Million USD | 22535.482% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -129250.205% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -150.591% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -26562.711% |
| Portage Biotech Inc. | -4.98 Million USD | -6259.948% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1408164.059% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -379.098% |
| OncoCyte Corporation | -6.56 Million USD | -4726.893% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 35400.246% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -6853.771% |
| Purple Biotech Ltd. | -14.13 Million USD | -2140.692% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1233.512% |
| scPharmaceuticals Inc. | -6.54 Million USD | -4740.168% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1797.831% |
| HilleVax, Inc. | -165.48 Million USD | -91.431% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -12381.836% |
| Tharimmune, Inc. | -10.93 Million USD | -2796.925% |
| Genprex, Inc. | -6.73 Million USD | -4601.788% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 14.104% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -258.116% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -22511.635% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -9450.623% |
| OKYO Pharma Limited | -826.84 Thousand USD | -38212.846% |
| Savara Inc. | 153 Thousand USD | 207151.634% |
| Curis, Inc. | -23.88 Million USD | -1226.198% |
| Daré Bioscience, Inc. | -5.15 Million USD | -6041.808% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -40722.693% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5002.916% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 26833.249% |
| BeiGene, Ltd. | -2.25 Billion USD | 85.94% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2667.484% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 47.914% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -70.697% |
| Erasca, Inc. | -37.21 Million USD | -751.217% |
| bluebird bio, Inc. | 108.57 Million USD | 391.78% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -24497.463% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 183.641% |
| DBV Technologies S.A. | -126.98 Million USD | -149.468% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -24497.463% |
| Moderna, Inc. | -2.9 Billion USD | 89.103% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2960.172% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2814.879% |
| Molecular Templates, Inc. | 707 Thousand USD | 44907.496% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -909.815% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 191.397% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -286.036% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -245.349% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -881.622% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -821.541% |
| MacroGenics, Inc. | -66.98 Million USD | -372.925% |
| RenovoRx, Inc. | -1.17 Million USD | -26906.735% |
| Adicet Bio, Inc. | -138.78 Million USD | -128.256% |
| Prime Medicine, Inc. | -27.94 Million USD | -1033.778% |
| Aditxt, Inc. | 18.12 Million USD | 1848.198% |
| Adagene Inc. | -87.62 Million USD | -261.518% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7505.197% |
| Quantum-Si incorporated | -118.55 Million USD | -167.204% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 979.847% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4138.44% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -553.052% |
| SciSparc Ltd. | -2.06 Million USD | -15240.872% |
| Vericel Corporation | 1.27 Million USD | 24907.283% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2541.735% |
| Minerva Neurosciences, Inc. | 41 Million USD | 872.576% |
| Generation Bio Co. | 31.44 Million USD | 1107.342% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -80.647% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -924.445% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 371.705% |
| Invivyd, Inc. | -198.47 Million USD | -59.611% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -250.935% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -13112.268% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -347.505% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -4541.597% |
| 2seventy bio, Inc. | 181.71 Million USD | 274.333% |
| ADMA Biologics, Inc. | 90.06 Million USD | 451.73% |
| Clene Inc. | 3.34 Million USD | 9584.701% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3387.827% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1372.684% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4809.487% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 7.943% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1118.434% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 278.306% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -7642.486% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 6433.247% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -5981.57% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -143.115% |
| Evaxion Biotech A/S | 5.28 Million USD | 6092.025% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -181.42% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -141.321% |
| Trevena, Inc. | 2.25 Million USD | 14129.628% |
| Surrozen, Inc. | -32.66 Million USD | -869.841% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -515.005% |
| Cingulate Inc. | 3.08 Million USD | 10376.405% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -10686.142% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4507.806% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3309.55% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -299.366% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -140.992% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -200.154% |
| Clearmind Medicine Inc. | -3.94 Million USD | -7934.952% |
| Kronos Bio, Inc. | -36.05 Million USD | -778.651% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3466.872% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 21825.748% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -483.878% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2297.42% |
| ImmunityBio, Inc. | 618.22 Million USD | 151.242% |
| Korro Bio, Inc. | -132.94 Million USD | -138.289% |
| Kineta, Inc. | -4.54 Million USD | -6876.195% |
| BioVie Inc. | -17.73 Million USD | -1686.503% |
| Codexis, Inc. | -43.27 Million USD | -632.105% |
| Celularity Inc. | 65.19 Million USD | 585.947% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -9896.497% |
| Celcuity Inc. | 6.78 Million USD | 4769.987% |
| Virax Biolabs Group Limited | -3.36 Million USD | -9314.391% |
| Cibus, Inc. | -8.07 Million USD | -3821.627% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -7390.873% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 7031.926% |
| IN8bio, Inc. | -16.38 Million USD | -1832.937% |
| Kodiak Sciences Inc. | -103.87 Million USD | -204.971% |
| Annexon, Inc. | -193.75 Million USD | -63.5% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 880069.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1710.326% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -8917.62% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 130.048% |
| Eyenovia, Inc. | 1.25 Million USD | 25267.911% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1277.435% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9668.393% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -852.835% |
| Arcellx, Inc. | -296.95 Million USD | -6.678% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1524.059% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -438.07% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1428.388% |
| Moolec Science SA | 117.61 Thousand USD | 269441.756% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -724.993% |
| Geron Corporation | 14.76 Million USD | 2246.122% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -735.458% |
| Royalty Pharma plc | 5.65 Billion USD | 105.599% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -124.004% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4432.405% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -5807.092% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -125.103% |
| Humacyte, Inc. | -22.48 Million USD | -1308.828% |
| Structure Therapeutics Inc. | -124.33 Million USD | -154.778% |
| 89bio, Inc. | -289.05 Million USD | -9.595% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1155.008% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -17667.19% |
| Genelux Corporation | -6.89 Million USD | -4491.81% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -919.959% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 478.939% |
| Notable Labs, Ltd. | -9.77 Million USD | -3140.477% |
| Liquidia Corporation | -80.17 Million USD | -295.117% |
| Mustang Bio, Inc. | -3.73 Million USD | -8379.363% |
| Immunovant, Inc. | -635.22 Million USD | 50.13% |
| Quantum-Si incorporated | -118.55 Million USD | -167.204% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1703.627% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -7546.367% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4046.543% |
| Acasti Pharma Inc. | -23 Million USD | -1277.044% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -9308.003% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1849.546% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -129.991% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -10065.347% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1324.924% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1606.01% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -87.141% |
| PepGen Inc. | -60.67 Million USD | -422.151% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1278.782% |
| United Therapeutics Corporation | -507.7 Million USD | 37.603% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1556.326% |
| Solid Biosciences Inc. | -47.75 Million USD | -563.432% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -36646.67% |
| Immuneering Corporation | -54.94 Million USD | -476.579% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -7436.336% |
| Silo Pharma, Inc. | -3.52 Million USD | -8888.687% |
| Belite Bio, Inc | -87.27 Million USD | -262.995% |
| XOMA Corporation | -29 Million USD | -992.376% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -348.094% |
| Bionomics Limited | 227 Million USD | 239.549% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -172.432% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -12406.475% |
| uniQure N.V. | -102.95 Million USD | -207.709% |
| Cassava Sciences, Inc. | -121.13 Million USD | -161.515% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7505.197% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 873.581% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2548.516% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -10138.155% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 298957.547% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9668.393% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3657.428% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4171.696% |
| Altimmune, Inc. | -134.48 Million USD | -135.554% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 259.942% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -12406.475% |
| Compugen Ltd. | -12.9 Million USD | -2354.967% |
| Peak Bio, Inc. | 10.34 Million USD | 3163.677% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -111839.576% |
| Benitec Biopharma Inc. | -50.58 Million USD | -526.288% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -203.618% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1712.568% |
| Zura Bio Limited | -99.8 Million USD | -217.405% |
| PolyPid Ltd. | 6.17 Million USD | 5234.344% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 527.4% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1712.568% |
| Instil Bio, Inc. | 75.35 Million USD | 520.379% |
| argenx SE | -2.02 Billion USD | 84.386% |
| Immunome, Inc. | -97.02 Million USD | -226.489% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1308.264% |
| Verona Pharma plc | -220.44 Million USD | -43.706% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -341.561% |
| Shattuck Labs, Inc. | -121.42 Million USD | -160.895% |
| CervoMed Inc. | -7.79 Million USD | -3965.126% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -70.777% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -7144.203% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -140.465% |
| Moolec Science SA | 117.61 Thousand USD | 269441.756% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -13745.812% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2092.587% |
| AnaptysBio, Inc. | -18.15 Million USD | -1645.298% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1645.394% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -350.106% |
| NeurAxis, Inc. | 145.7 Thousand USD | 217525.532% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2920.415% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1011.813% |
| Achilles Therapeutics plc | -126.92 Million USD | -149.59% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -341.561% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -48210.89% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1424.943% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 21825.748% |
| Nutriband Inc. | -251.65 Thousand USD | -125781.259% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2305.201% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4157.917% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 193.119% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1434.691% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 29.205% |
| Palisade Bio, Inc. | -12.06 Million USD | -2526.121% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -125.776% |
| Beam Therapeutics Inc. | -262.72 Million USD | -20.58% |
| Neurogene Inc. | -131.95 Million USD | -140.074% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1552.095% |
| AEON Biopharma, Inc. | -4.88 Million USD | -6391.578% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 16.014% |
| Sesen Bio, Inc. | -112.55 Million USD | -181.458% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -217.233% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -13393.055% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -711.738% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -280.381% |
| Athira Pharma, Inc. | -88.99 Million USD | -255.947% |
| Vaccinex, Inc. | -1.28 Million USD | -24495.419% |
| HCW Biologics Inc. | 2.85 Million USD | 11189.427% |
| XOMA Corporation | -29 Million USD | -992.376% |
| Nektar Therapeutics | 210.24 Million USD | 250.68% |
| Arvinas, Inc. | -313.8 Million USD | -0.953% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 19620.054% |
| Merus N.V. | -192.88 Million USD | -64.238% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 628.114% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4465.999% |
| Rezolute, Inc. | -68.16 Million USD | -364.718% |
| Clene Inc. | 3.34 Million USD | 9584.701% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2302.283% |
| BeyondSpring Inc. | -13.75 Million USD | -2203.083% |
| Synlogic, Inc. | -6.68 Million USD | -4638.803% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 28035.538% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3646.765% |
| Peak Bio, Inc. | 10.34 Million USD | 3163.677% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -284.359% |
| Krystal Biotech, Inc. | -350.23 Million USD | 9.549% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 355.218% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -87.454% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -9934.037% |
| MannKind Corporation | 143.89 Million USD | 320.147% |
| Ikena Oncology, Inc. | -109.15 Million USD | -190.217% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4084.243% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -857.066% |
| Gossamer Bio, Inc. | 180.35 Million USD | 275.647% |
| CohBar, Inc. | -5.93 Million USD | -5241.483% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -964.909% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7037.998% |
| Legend Biotech Corporation | -949.39 Million USD | 66.633% |
| Mural Oncology plc | -255.84 Million USD | -23.822% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1083.359% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -6624.964% |
| Disc Medicine, Inc. | -358.28 Million USD | 11.581% |
| Champions Oncology, Inc. | 4.81 Million USD | 6683.313% |
| REGENXBIO Inc. | 54.76 Million USD | 678.42% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -117706.156% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -109.761% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3415.189% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -292.634% |
| Vaxart, Inc. | -8.24 Million USD | -3744.06% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -531.306% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -149.115% |
| Cellectis S.A. | -43.85 Million USD | -622.355% |
| Longeveron Inc. | -2.9 Million USD | -10793.707% |
| Repare Therapeutics Inc. | -107.85 Million USD | -193.709% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 132.713% |
| Inozyme Pharma, Inc. | 12 Million USD | 2739.029% |
| Revolution Medicines, Inc. | -608.2 Million USD | 47.914% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -25655.203% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -19.49% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -111.091% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1924.599% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -42709.324% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.688% |
| Denali Therapeutics Inc. | -74.86 Million USD | -323.147% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2541.735% |
| Veru Inc. | 4.77 Million USD | 6727.428% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2716.904% |
| Cingulate Inc. | 3.08 Million USD | 10376.405% |
| Passage Bio, Inc. | 4.58 Million USD | 7009.248% |
| Context Therapeutics Inc. | -14.44 Million USD | -2092.338% |
| Exicure, Inc. | 5.84 Million USD | 5516.122% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -37.51% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -700.579% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2118.922% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -438.564% |
| Nuvalent, Inc. | -335.38 Million USD | 5.545% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 18365.67% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -325.323% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3463.431% |
| OmniAb, Inc. | 9.2 Million USD | 3542.236% |
| Anew Medical, Inc. | 1.43 Million USD | 22214.956% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2033.792% |
| Lipocine Inc. | -4.75 Million USD | -6562.801% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -188.441% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2179.896% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -525.336% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1372.654% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -4613.421% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -381.245% |
| Ocugen, Inc. | -32.52 Million USD | -874.106% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -270.189% |
| Q32 Bio Inc. | -37.94 Million USD | -734.798% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -50344.108% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2241.555% |
| Equillium, Inc. | -22.39 Million USD | -1314.742% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1139.006% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -870.948% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -127681.296% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 336.336% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 10005.847% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 96552.331% |
| Dominari Holdings Inc. | 195 Thousand USD | 162555.897% |
| Edesa Biotech, Inc. | -5.26 Million USD | -5914.703% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3452.641% |
| Bio-Techne Corporation | 267.74 Million USD | 218.317% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1854.402% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -168.252% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3669.951% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2404.063% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -29.239% |
| Nkarta, Inc. | 57.29 Million USD | 652.87% |
| BioCardia, Inc. | 212 Thousand USD | 149528.774% |
| Iterum Therapeutics plc | 13.43 Million USD | 2457.412% |